-
26-11-2020, 08:45 PM
#651
Originally Posted by whatsup
Didn't this "outfit ' have its genisus in Aussie all those years ago, something like 10-15 ?
May be a case of "being born again"..?
-
27-11-2020, 04:11 AM
#652
Member
Originally Posted by percy
That $2 mil will not go very far.
They will need a great deal more capital within 6 months.
Perhaps that is why the ASX listing.?
They had $4.4 million in bank 30 Sept. forecasting $2.6 million cash burn this year.
The company is pretty clear what they plan to do with the extra funds from the capital raise.
Investment in team capabilities for $200,000 business expansion
Establish device manufacturing in $300,000 China for Chinese operations
Reduce the cost of the product via $300,000 R&D initiatives
Market development through market $200,000 access/medical affairs capability
Costs associated with the offer $300,000 and dual listing
General working capital $200,000
Total $1,500,000
I would think they have enough funds to get them through the next 6 months. The Pitt Strret report put out with the announcement notes a require for further capital.
– Funding. Post TRU’s raise of NZ$5.2M in FY21, our modelling assumes a further equity raise of NZ$3M at NZ$0.09 per share, after which we expect TRU will have sufficient liquidity to sustainably fund its operations going forward.
After raising this $1.5 - $2 million with the ASX listing they will hopefully be in a strong cash position for the next 18-24 months. It will be interesting to see how supported this share is on the ASX. If they continue achieving there goals then times ahead could be great.
-
03-12-2020, 09:10 PM
#653
Member
-
03-12-2020, 09:49 PM
#654
Originally Posted by HITMAN
They had $4.4 million in bank 30 Sept. forecasting $2.6 million cash burn this year.
The company is pretty clear what they plan to do with the extra funds from the capital raise.
Investment in team capabilities for $200,000 business expansion
Establish device manufacturing in $300,000 China for Chinese operations
Reduce the cost of the product via $300,000 R&D initiatives
Market development through market $200,000 access/medical affairs capability
Costs associated with the offer $300,000 and dual listing
General working capital $200,000
Total $1,500,000
I would think they have enough funds to get them through the next 6 months. The Pitt Strret report put out with the announcement notes a require for further capital.
– Funding. Post TRU’s raise of NZ$5.2M in FY21, our modelling assumes a further equity raise of NZ$3M at NZ$0.09 per share, after which we expect TRU will have sufficient liquidity to sustainably fund its operations going forward.
After raising this $1.5 - $2 million with the ASX listing they will hopefully be in a strong cash position for the next 18-24 months. It will be interesting to see how supported this share is on the ASX. If they continue achieving there goals then times ahead could be great.
rinse repeat, rinse repeat, rinse repeat, rinse repeat, rinse repeat, rinse repeat, rinse repeat, rinse repeat, rinse repeat, rinse repeat, rinse repeat again and again and again until the poor sods get sick of funding this-------, whatever !
-
09-12-2020, 03:04 PM
#655
Member
as at 08:31:01, Wednesday 09 December, 2020 (NZDT)
OFFER: TRU: Public Offer Acceptance Reaches Target NZ$1.5 Million
TRU
09/12/2020 08:31
OFFER
PRICE SENSITIVE
REL: 0831 HRS TruScreen Group Limited
OFFER: TRU: Public Offer Acceptance Reaches Target NZ$1.5 Million
NZX Announcement
9 December 2020
PUBLIC OFFER ACCEPTANCE REACHES TARGET NZ$1.5 MILLION
As announced to the market on 9 and 26 November 2020, cervical cancer
screening technology company, TruScreen Group Limited (NZX: TRU)(TruScreen or
the Company) capital raising initiative, by way of a public offer, to raise
up to NZD$2 million ("Offer") in conjunction with TruScreen's application for
the dual listing of its shares on the Australian Securities Exchange (ASX),
closes on 18 December 2020.
TruScreen is pleased to advise that acceptances have already achieved the
planned raise of NZ$1.5m and the Board has resolved to accept further
applications of up to NZ$500,000 as oversubscriptions, per the maximum raise
of NZ$2 million as stated in the Product Disclosure Statement (PDS).
Applications can be made through the online application portal at
https://www.truscreenshareoffer.co.nz/. A copy of the registered PDS in
support of the Offer is available on the online application portal.
Australian applications can be made at www.onmarket.com.au
An application has been made to the ASX for TruScreen to be admitted to the
Official List of ASX as an ASX Foreign Exempt Listing and for quotation of
the new shares to be offered in Australia on the ASX.
If TruScreen is admitted to the official list of ASX, then those Australian
based investors in the Offer will initially have their Shares quoted on the
ASX. Once dual listed, shareholders can select either the Australian or New
Zealand sub-register to hold their shares to suit their investment needs.
The Offer is conditional upon the ASX approving the admission of TruScreen to
the Official List of the ASX as an ASX Foreign Exempt Listing and for the
quotation of the new shares issued to Australian investors on the ASX on or
before that Closing Date (as that date may be varied from time to time). In
the event that this condition is not satisfied, then the Offer will not
proceed, and all application moneys received by the Company will be refunded
to investors in full and without deduction within 5 business days.
-ENDS-
-
09-12-2020, 03:43 PM
#656
Originally Posted by Pegasus2000
as at 08:31:01, Wednesday 09 December, 2020 (NZDT)
OFFER: TRU: Public Offer Acceptance Reaches Target NZ$1.5 Million
TRU
09/12/2020 08:31
OFFER
PRICE SENSITIVE
REL: 0831 HRS TruScreen Group Limited
OFFER: TRU: Public Offer Acceptance Reaches Target NZ$1.5 Million
NZX Announcement
9 December 2020
PUBLIC OFFER ACCEPTANCE REACHES TARGET NZ$1.5 MILLION
As announced to the market on 9 and 26 November 2020, cervical cancer
screening technology company, TruScreen Group Limited (NZX: TRU)(TruScreen or
the Company) capital raising initiative, by way of a public offer, to raise
up to NZD$2 million ("Offer") in conjunction with TruScreen's application for
the dual listing of its shares on the Australian Securities Exchange (ASX),
closes on 18 December 2020.
TruScreen is pleased to advise that acceptances have already achieved the
planned raise of NZ$1.5m and the Board has resolved to accept further
applications of up to NZ$500,000 as oversubscriptions, per the maximum raise
of NZ$2 million as stated in the Product Disclosure Statement (PDS).
Applications can be made through the online application portal at
https://www.truscreenshareoffer.co.nz/. A copy of the registered PDS in
support of the Offer is available on the online application portal.
Australian applications can be made at www.onmarket.com.au
An application has been made to the ASX for TruScreen to be admitted to the
Official List of ASX as an ASX Foreign Exempt Listing and for quotation of
the new shares to be offered in Australia on the ASX.
If TruScreen is admitted to the official list of ASX, then those Australian
based investors in the Offer will initially have their Shares quoted on the
ASX. Once dual listed, shareholders can select either the Australian or New
Zealand sub-register to hold their shares to suit their investment needs.
The Offer is conditional upon the ASX approving the admission of TruScreen to
the Official List of the ASX as an ASX Foreign Exempt Listing and for the
quotation of the new shares issued to Australian investors on the ASX on or
before that Closing Date (as that date may be varied from time to time). In
the event that this condition is not satisfied, then the Offer will not
proceed, and all application moneys received by the Company will be refunded
to investors in full and without deduction within 5 business days.
-ENDS-
IMHO POOR dumb suckers, rinse and repeat etc etc !
-
09-12-2020, 06:17 PM
#657
Member
Originally Posted by whatsup
IMHO POOR dumb suckers, rinse and repeat etc etc !
Yeah we get it whatsup. Your actually just repeating yourself. And 2 million isn't a lot of money to raise for a company like TRU. Ever heard of inflection?
-
09-12-2020, 07:13 PM
#658
......move over PEB. Truscreen will very soon become the next big thing on the NZX. Gathering steam right now..........13-22c Pitt Research valuation highly doable IMHO. Lets just see who's right Wattapp or Pitt. My hard earned money (and lots of it) on the latter.
-
09-12-2020, 07:48 PM
#659
Member
Originally Posted by whatsup
IMHO POOR dumb suckers, rinse and repeat etc etc !
Originally Posted by Lion_graf
Yeah we get it whatsup. Your actually just repeating yourself. And 2 million isn't a lot of money to raise for a company like TRU. Ever heard of inflection?
The guy has been repeating himself for years. So bitter and sad. He didn't answer a question a couple of us posed recently. Is he a holder? I think he got burned and lost his money from their previous life so he feels compelled to vent anytime there's and update from TRU to make himself feel better.
Will he explain himself as to why he's been so bitter for at least the last 6 years on this forum? Unlikely.
-
09-12-2020, 08:58 PM
#660
A picture says a thousand words as they say.
https://stocknessmonster.com/charts/tru.nzx/
Some shares just do not have wings
Never held and never will hold
I get concerned when see investors putting their hard earned money here
Last edited by kiora; 09-12-2020 at 09:05 PM.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks